Loss of response and frequency of adverse events in patients with ulcerative colitis and Crohn’s disease when switching from the original infliximab to its biosimilars - PDF (Russian)
Copyright (c) 2021 Consilium Medicum
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.